Blood Disorder Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Bleeding Disorders Treatment Market Analysis and is segmented By Product Type (Plasma Derived Factors, Recombinant Factors, Others), By Application and Geography.

Blood Disorder Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Blood Disorder Therapeutics Market Size

bleeding disorders therapeutics market size
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 6.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

bleeding disorders therapeutics market key players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Blood Disorder Therapeutics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Blood Disorder Therapeutics Market Analysis

The Blood Disorder Therapeutics Market is expected to register a CAGR of 6.2% during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the blood disorder therapeutics market due to rising prevalence of various blood disorders and increasing awareness among the patient population in this region. According to the World Federation of Hemophilia, in the United States alone there are around 18 thousand people with hemophilia and over 11 thousand with von Willebrand disease. In addition, Hemophilia A affects 1 in 5,000 male births and approximately 400 babies are born with hemophilia A each year. Furthermore, increasing investments in research and development to develop treatment options for blood disorders and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

bleeding disorders therapeutics market analysis

Blood Disorder Therapeutics Industry Overview

The Blood Disorder Therapeutics  Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi, Novo Nordisk A/S, CSL Ltd, Pfizer Inc, Bayer AG, Celgene Corporation, Alexion Pharmaceuticals, Inc, Amgen Inc and AstraZeneca Plc.

Blood Disorder Therapeutics Market Leaders

  1. Takeda Pharmaceutical Company Limited (Shire Plc)

  2. Sanofi

  3. Novo Nordisk A/S

  4. CSL Ltd

  5. Pfizer Inc

  6. *Disclaimer: Major Players sorted in no particular order
Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi, Novo Nordisk A/S, CSL Ltd, Pfizer Inc, Bayer AG, Celgene Corporation, Alexion Pharmaceuticals, Inc
Need More Details on Market Players and Competiters?
Download PDF

Blood Disorder Therapeutics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Various Blood Disorders
    • 4.2.2 Increasing Investment in R&D for Advance Treatment Options
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Treatment
    • 4.3.2 Stringent Regulations Norms
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Plasma Derived Factors
    • 5.1.2 Recombinant Factors
    • 5.1.3 Other Products
  • 5.2 By Application
    • 5.2.1 Hemoglobin Diosrders
    • 5.2.2 Platelet Based Disorders
    • 5.2.3 Plasma Disorders
    • 5.2.4 Myeloproliferative Disorders
    • 5.2.5 Genetic Hematology Disorders
    • 5.2.6 Blood Cancers
    • 5.2.7 Other Application
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Takeda Pharmaceutical Company Limited (Shire Plc)
    • 6.1.2 Sanofi
    • 6.1.3 Novo Nordisk A/S
    • 6.1.4 CSL Ltd
    • 6.1.5 Pfizer Inc
    • 6.1.6 Bayer AG
    • 6.1.7 Celgene Corporation
    • 6.1.8 Alexion Pharmaceuticals, Inc
    • 6.1.9 Amgen Inc
    • 6.1.10 AstraZeneca Plc
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Blood Disorder Therapeutics Industry Segmentation

Blood disorders are conditions that impact the blood's ability to function correctly. Most blood disorders decrease the number of platelets, proteins, nutrients or interfere with their function. Blood disorders covered under the market scope include anemia, bleeding disorders such as hemophilia, and blood cancers such as lymphoma, leukemia, and myeloma among others. Blood Disorder Therapeutics Market is segmented By Product Type, By Application and Geography.

By Product Type Plasma Derived Factors
Recombinant Factors
Other Products
By Application Hemoglobin Diosrders
Platelet Based Disorders
Plasma Disorders
Myeloproliferative Disorders
Genetic Hematology Disorders
Blood Cancers
Other Application
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Blood Disorder Therapeutics Market Research FAQs

What is the current Blood Disorder Therapeutics Market size?

The Blood Disorder Therapeutics Market is projected to register a CAGR of 6.2% during the forecast period (2025-2030)

Who are the key players in Blood Disorder Therapeutics Market?

Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi, Novo Nordisk A/S, CSL Ltd and Pfizer Inc are the major companies operating in the Blood Disorder Therapeutics Market.

Which is the fastest growing region in Blood Disorder Therapeutics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Blood Disorder Therapeutics Market?

In 2025, the North America accounts for the largest market share in Blood Disorder Therapeutics Market.

What years does this Blood Disorder Therapeutics Market cover?

The report covers the Blood Disorder Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Blood Disorder Therapeutics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Our Best Selling Reports

Dental Crowns and Bridges Industry Report

Statistics for the 2025 Blood Disorder Therapeutics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Blood Disorder Therapeutics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Bleeding Disorders Treatment Market Report Snapshots